Anti-CEA Antibody (OAAI00177)

CEACAM5

Carcinoembryonic antigen (CEA), is synthesized during development in the fetal gut, and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. Antibody to CEA is found in various metastatic adenocarcinomas and in pulmonary adenocarcinomas. Carcinoembryonic antigen (CEA), tumour-associated glycoprotein-72 (TAG-72), folate receptor-a (FRa) and Epithelial growth factor receptor (EGFR) are most sensitive and specific common markers in colorectal cancer-specific biomarkers which have been used as molecular targets for fluorescent intra-opeRative imaging, targeted PET/MRI, and selective cytotoxic drμ g delivery.

A synthetic peptide corresponding to internal sequence of Human CEA.